JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥13,196 | ¥18,756 | ¥13,278 | ¥30,733 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥244 |
| Receivables | ¥12,236 | ¥14,934 | ¥11,137 | ¥15,585 |
| Inventory | ¥21,758 | ¥20,933 | ¥18,514 | ¥14,636 |
| Other Curr. Assets | ¥3,866 | ¥2,958 | ¥4,873 | ¥990 |
| Total Curr. Assets | ¥51,056 | ¥57,581 | ¥47,802 | ¥62,188 |
| Property Plant & Equip (Net) | ¥37,410 | ¥30,040 | ¥32,681 | ¥26,782 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥2,960 | ¥3,496 | ¥3,652 | ¥2,960 |
| Long-Term Investments | ¥9,629 | ¥9,120 | ¥8,867 | ¥2,230 |
| Tax Assets | ¥2,985 | ¥0 | ¥1,357 | ¥2,433 |
| Other NC Assets | ¥815 | ¥1,989 | ¥576 | ¥539 |
| Total NC Assets | ¥53,799 | ¥44,645 | ¥47,133 | ¥34,944 |
| Other Assets | ¥2 | ¥3 | ¥2 | ¥2 |
| Total Assets | ¥104,855 | ¥102,226 | ¥94,937 | ¥97,134 |
| Liabilities | – | – | – | – |
| Payables | ¥590 | ¥890 | ¥1,563 | ¥1,324 |
| Short-Term Debt | ¥26,055 | ¥8,950 | ¥17,300 | ¥15,150 |
| Tax Payable | ¥0 | ¥1,657 | ¥33 | ¥5,915 |
| Deferred Revenue | ¥0 | ¥1,657 | ¥3,924 | ¥12,108 |
| Other Curr. Liab. | ¥16,091 | ¥15,893 | ¥11,887 | ¥12,468 |
| Total Curr. Liab. | ¥43,988 | ¥30,135 | ¥35,762 | ¥42,054 |
| LT Debt | ¥12,050 | ¥14,350 | ¥5,500 | ¥2,950 |
| Deferred Rev, NC | ¥0 | -¥441 | -¥428 | -¥343 |
| Deferred Tax Liab, NC | ¥595 | ¥441 | ¥428 | ¥343 |
| Other NC Liab. | ¥1,380 | ¥1,268 | ¥1,262 | ¥1,044 |
| Total NC Liab. | ¥13,430 | ¥15,618 | ¥6,763 | ¥3,994 |
| Other Liabilities | ¥0 | -¥1 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥82 | ¥73 | ¥44 |
| Total Liabilities | ¥57,418 | ¥45,752 | ¥42,525 | ¥46,048 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥49,697 |
| Common Stock | ¥9,061 | ¥9,061 | ¥9,061 | ¥9,061 |
| Retained Earnings | ¥31,191 | ¥37,278 | ¥34,273 | ¥33,241 |
| AOCI | ¥1,460 | ¥2,416 | ¥1,421 | ¥1,184 |
| Other Equity | ¥5 | ¥2 | ¥0 | ¥0 |
| Total Equity | ¥47,043 | ¥56,178 | ¥52,161 | ¥50,881 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥392 | ¥297 | ¥251 | ¥205 |
| Total Liab. & Tot. Equity | ¥104,855 | ¥102,226 | ¥94,937 | ¥97,134 |
| Net Debt | ¥24,909 | ¥4,544 | ¥9,522 | -¥12,633 |